Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More